Patient Voice Needed In Outcomes-Based Contracts, PhRMA Exec Says

PhRMA President and CEO Stephen Ubl says patient preferences can be among metrics in outcomes-based arrangements between biopharma and payers; experimentation needed before US government gets involved in value-based pricing.